Mepolizumab 100 MG [Nucala]

DRUG3 trials

Sponsors

University of Sao Paulo General Hospital, Aristotle University Of Thessaloniki

Conditions

AsthmaAsthma; EosinophilicChronic Rhinosinusitis With Nasal PolypsEosinophilic AsthmaLate-Onset AsthmaSevere Asthma

Phase 4

A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil

University of Sao Paulo General HospitalEosinophilic Asthma

Start: 2020-01-09End: 2021-12-31Target: 18Updated: 2020-01-14

Unknown Phase

Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)

Active, not recruitingNCT04612556

Aristotle University Of ThessalonikiAsthma; Eosinophilic, Late-Onset Asthma, Severe Asthma

Start: 2021-01-22End: 2025-03-15Target: 45Updated: 2024-02-21

Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma

RecruitingNCT05708300

Aristotle University Of ThessalonikiAsthma, Chronic Rhinosinusitis With Nasal Polyps

Start: 2024-02-23End: 2027-03-01Target: 57Updated: 2024-03-08

Related Papers

Effect of Mepolizumab on airways remodeling in patients with late-onset severe eosinophilic asthma and fixed obstruction (preliminary data of the MESILICO study)

2023-09-0912 citations